PAM
AGTC

Panagora Asset Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Panagora Asset Management’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-447
Closed -$2K – 2983
2020
Q4 		$2K Hold
447
– – ﹤0.01% 2670
2020
Q3 		$2K Sell
447
-653
-59% -$3.57K ﹤0.01% 2614
2020
Q2 		$6K Hold
1,100
– – ﹤0.01% 2328
2020
Q1 		$4K Hold
1,100
– – ﹤0.01% 2323
2019
Q4 		$5K Sell
1,100
-8,749
-89% -$27.7K ﹤0.01% 2262
2019
Q3 		$41K Sell
9,849
-1,113
-10% -$4.02K ﹤0.01% 1997
2019
Q2 		$42K Sell
10,962
-239
-2% -$979 ﹤0.01% 2122
2019
Q1 		$47K Sell
11,201
-65,625
-85% -$229K ﹤0.01% 2056
2018
Q4 		$191K Buy
76,826
+68,807
+858% +$403K ﹤0.01% 1626
2018
Q3 		$59K Sell
8,019
-31,519
-80% -$138K ﹤0.01% 1991
2018
Q2 		$146K Sell
39,538
-42,806
-52% -$198K ﹤0.01% 1754
2018
Q1 		$317K Buy
82,344
+12,950
+19% +$54.4K ﹤0.01% 1537
2017
Q4 		$250K Buy
69,394
+19,953
+40% +$75.3K ﹤0.01% 1599
2017
Q3 		$195K Buy
49,441
+49,402
+126,672% +$227K ﹤0.01% 1692
2017
Q2 		$0 Sell
39
-254,490
-100% -$1.43M ﹤0.01% 2683
2017
Q1 		$1.76M Buy
254,529
+26,420
+12% +$206K 0.01% 926
2016
Q4 		$2.13M Buy
228,109
+31,847
+16% +$287K 0.01% 878
2016
Q3 		$1.92M Sell
196,262
-29,434
-13% -$397K 0.01% 921
2016
Q2 		$3.19M Buy
225,696
+29,881
+15% +$466K 0.02% 705
2016
Q1 		$2.74M Buy
195,815
+66,952
+52% +$982K 0.01% 764
2015
Q4 		$2.63M Buy
128,863
+46,449
+56% +$717K 0.01% 724
2015
Q3 		$1.08M Buy
82,414
+17,959
+28% +$298K 0.01% 1003
2015
Q2 		$989K Buy
64,455
+61,552
+2,120% +$1.18M 0.01% 1095
2015
Q1 		$58K Buy
2,903
+1,860
+178% +$41.6K ﹤0.01% 2060
2014
Q4 		$22K Sell
1,043
-4,436
-81% -$90.3K ﹤0.01% 2160
2014
Q3 		$102K Hold
5,479
– – ﹤0.01% 1861
2014
Q2 		$127K Buy
+5,479
New +$96.5K ﹤0.01% 1875

Other funds holding AGTC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Panagora Asset Management's AGTC Position: Q1 2021 in Review

Panagora Asset Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q1 2021, closing a stake of 447 shares — an estimated $2K sold.

Panagora Asset Management first reported a position in AGTC in Q2 2014 and held it in 27 quarters. The position peaked at $3.19M in Q2 2016. 82 funds tracked by Wall St. Rank hold AGTC as of Q1 2021.

  • Panagora Asset Management reported no remaining Applied Genetic Technologies Corporation position as of Q1 2021 after selling out during the quarter.
  • Panagora Asset Management sold 447 Applied Genetic Technologies Corporation shares in Q1 2021, an estimated $2K.
  • Panagora Asset Management first reported a position in Applied Genetic Technologies Corporation in Q2 2014 and held it in 27 quarters.
  • Panagora Asset Management's Applied Genetic Technologies Corporation position peaked at $3.19M in Q2 2016.
  • 82 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q1 2021.

Based on Panagora Asset Management's 13F filing for Q1 2021, filed 12 May 2021.